Sonendo Launches ProControl for the GentleWave G4 System

Sonendo, Inc. (OTCQX: SONX) (“Sonendo”), a leading dental technology company and developer of the GentleWave System, has announced the launch of ProControl as the company’s latest advancement in endodontic care. The ProControl software update enables optimized cleaning of complex anatomy and increased procedural efficiency.

ProControl allows endodontists to adjust procedure fluid concentration levels when using the CleanFlow procedure instrument, tailoring treatments to each patient’s unique needs. This advancement expands the clinical flexibility of the GentleWave G4 System, enabling optimal clinical outcomes and improving patient experience through personalized treatment.

“ProControl for the GentleWave G4 represents our commitment to continued product innovation,” said Bjarne Bergheim, president and chief executive officer of Sonendo. “The GentleWave G4 Console was designed with the future in mind, and this upgrade will allow our G4 users the opportunity to reduce procedure time and further facilitate the transition toward non-instrumentation endodontics. No other endodontic system can automatically and precisely adjust fluid concentrations during treatment. Sonendo remains dedicated to meeting the evolving needs of endodontists and their patients by advancing dental care through technology. With the launch of ProControl, we are thrilled to provide our customers the ability to fine-tune patient care.”

Kevin Yein, vice president of R&D, added, “We are excited to introduce ProControl as part of our ongoing commitment to evolving endodontic innovation to provide more personalized care for patients. Our G4 technology underscores our dedication to providing endodontists with the tools to help them transform root canal treatment within their practices and provide better care to their patients.”

ProControl for the GentleWave G4 system is available now. For more information about the GentleWave G4 with ProControl or to schedule a demonstration, please visit www.sonendo.com or contact your local sales representative.

About Sonendo

Sonendo is a commercial-stage medical technology company focused on saving teeth from tooth decay, the most prevalent chronic disease globally. Sonendo develops and manufactures the GentleWave System, an innovative technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The system utilizes a proprietary mechanism of action, which combines procedure fluid optimization, broad-spectrum acoustic energy, and advanced fluid dynamics to debride and disinfect deep regions of the complex root canal system in a less invasive procedure that preserves tooth structure.

The clinical benefits of the GentleWave System, when compared to conventional methods of root canal therapy, include improved clinical outcomes, such as superior cleaning that is independent of root canal complexity and tooth anatomy, high and rapid rates of healing, and minimal to no post-operative pain. Additionally, the GentleWave System can improve the workflow and economics of dental practices and offers patients an effective, less invasive, and less painful alternative to traditional root canal therapy.

Forward-Looking Statements

This press release includes forward-looking statements (statements which are not historical facts) within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, express or implied forward-looking statements related to the company’s anticipated business and financial performance on an ongoing basis. You are cautioned that such statements are not guarantees of future performance, and that our actual results may differ materially from those set forth in the forward-looking statements. Forward-looking statements are predictions, projections, and other statements about future events that are based on current expectations and assumptions; they speak only as of the date they are made and, as a result, are subject to risks and uncertainties that may change at any time.

Factors that could cause the company’s actual results to differ materially from these forward-looking statements are described in detail in our registration statements, reports, and other filings with the Securities and Exchange Commission, including the “Risk Factors” set forth in our Annual Report on Form 10-K, as supplemented by our quarterly reports on Form 10-Q. Such filings are available on our website or at www.sec.gov. We undertake no obligation to publicly update or revise forward-looking statements to reflect subsequent developments, events, or circumstances, except as required under applicable securities laws. Readers are cautioned not to place undue reliance on forward-looking statements, and the company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.